PFE · News · 20260913N
Litigation and Legal Risk
PFIZER INC · 2026-09-13 · Importance 64 · Surprise 42 · In source text
Pfizer is pursuing payment in a dispute involving Poland and Romania over more than 90 million unwanted COVID-19 vaccine doses. The contracts are valued at approximately $2 billion, creating a material potential recovery for Pfizer and liability for the counterparties. Pfizer is attempting to enforce the contracts by targeting air-traffic-control fees, while regulators in Poland and Romania warn that the action could jeopardize air safety.
Key facts
- The matter is characterized as a $2 billion fight over unwanted Covid-19 vaccines. source
- Pfizer is taking an unusual approach to recover payment for unwanted Covid-19 vaccines, targeting air-traffic control fees in its dispute with Poland and Romania. source
- Regulators in Poland and Romania warn Pfizer's move to target air-traffic control fees could jeopardize air safety. source
- The dispute concerns pandemic-era contracts for over 90 million shots that are no longer needed. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| liability | positive | contingent | +0.1% | The matter is characterized as a $2 billion fight over unwanted Covid-19 vaccines. |
| assets | positive | contingent | — | Pfizer is taking an unusual approach to recover payment for unwanted Covid-19 vaccines, targeting air-traffic control fees in its dispute… |
| liability | negative | contingent | — | Regulators in Poland and Romania warn Pfizer's move to target air-traffic control fees could jeopardize air safety. |